Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell sources for bioartificial liver support

J Stange1, S Mitzner

  • 1Department of Internal Medicine, University of Rostock, Germany.

The International Journal of Artificial Organs
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Role of MARS® dialysis in acute-on-chronic liver failure].

Zeitschrift fur Gastroenterologie·2013
Same author

Ciprofloxacin reduces the risk of hemolytic uremic syndrome in patients with Escherichia coli O104:H4-associated diarrhea.

Infection·2013
Same author

Atypical electrolyte kinetics during an emergency dialysis session in a patient with Leriche syndrome.

Clinical nephrology·2010
Same author

Prolonged survival of renal allograft in rats by methotrexate-albumin conjugates as immunosuppressive therapy.

Transplantation proceedings·2008
Same author

Albumin-bound substances--a new target in liver failure therapy.

Zeitschrift fur Gastroenterologie·2005
Same author

Albumin binding capacity (ABiC) is reduced in commercially available human serum albumin preparations with stabilizers.

Zeitschrift fur Gastroenterologie·2005
Same journal

Carboxyhemoglobin levels for the detection of hemolysis in patients supported by left ventricular assist devices: A case series.

The International journal of artificial organs·2026
Same journal

Evaluation of arteriovenous fistulas of obtuse anastomosis in reducing thrombosis using computational fluid dynamics.

The International journal of artificial organs·2026
Same journal

Aggravated sepsis, acute kidney injury, and microbiological resistance: Four year's pre-post COVID-19 outcome study.

The International journal of artificial organs·2026
Same journal

Integrative multi-modal feature extraction from ECG signals using FusionHeartNet for robust heart disease prediction.

The International journal of artificial organs·2026
Same journal

Reply from the author to "Comparison of the liver support systems OPAL and ALBUNIQUE in critically ill patients with liver dysfunction".

The International journal of artificial organs·2026
Same journal

Clarifying clinical impact and methodological considerations in the comparison of OPAL and ALBUNIQUE systems.

The International journal of artificial organs·2026
See all related articles

Choosing the right cells is crucial for bioartificial liver success. This review examines hepatocyte sources, highlighting the need for differentiated cells and discussing current limitations.

Area of Science:

  • Hepatology and Regenerative Medicine
  • Biomaterials and Biomedical Engineering

Background:

  • Bioartificial liver (BAL) devices aim to support liver function through biological means.
  • Effective BALs require cell sources capable of plasma protein synthesis, detoxification, and metabolic regulation.
  • The demand for highly differentiated hepatocytes presents a significant challenge in current research.

Purpose of the Study:

  • To review and evaluate various hepatocyte sources for bioartificial liver applications.
  • To identify the essential functional requirements for cells used in liver support systems.
  • To analyze the discrepancies between ideal cell source characteristics and current technological capabilities.

Main Methods:

  • Literature review of existing studies on hepatocyte sourcing for bioartificial livers.

Related Experiment Videos

  • Analysis of functional requirements including protein synthesis, detoxification, and regulation.
  • Comparative evaluation of primary hepatocytes versus established cell lines.

    • Main Results:

    • Highly differentiated hepatocytes are essential for optimal bioartificial liver function.
    • Current cell sources often fall short of the required differentiation and functional capacity.
    • Established cell lines have limitations that restrict their efficacy in bioartificial liver applications.

    Conclusions:

    • The success of bioartificial liver technology is intrinsically linked to the choice of cell source.
    • Bridging the gap between desired cell function and available cell sources is critical for future development.
    • Further research into novel hepatocyte sources and differentiation strategies is warranted.